Survival of bladder or renal cancer in patients with CHEK2 mutations. Zlowocka-Perlowska E, Debniak T, Slojewski M, van de Wetering T, et al. PLoS One 2021;16:e0257132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zlowocka-Perlowska E, Debniak T, Slojewski M, van de Wetering T, et al. Survival of bladder or renal cancer in patients with CHEK2 mutations. PLoS One 2021;16:e0257132.
PMID: 34499690